Intranasal influenza trivalent vaccine (Advagene Biopharma)

N/A

Report date: 2023/11/01 20:08:59

Base Information

Drug NameIntranasal influenza trivalent vaccine (Advagene Biopharma)

Drug Alias NameInactivated trivalent seasonal influenza vaccine鼻内流感三价疫苗-Advagene BiopharmaInactivated trivalent influenza vaccineNasal influenza vaccineInfluenza vaccine intranasal +[6]

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAdvagene Biopharma Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAdvagene Biopharma Co Ltd

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A